C07D 211/36
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D211/36 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 5,042 US grants and 4,400 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,042
- Published applications
- 4,400
- Assignees
- 1,686
- Inventors
- 12,718
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 49 | 0 |
| 1977 | 81 | 0 |
| 1978 | 105 | 0 |
| 1979 | 66 | 0 |
| 1980 | 72 | 0 |
| 1981 | 66 | 0 |
| 1982 | 67 | 0 |
| 1983 | 59 | 0 |
| 1984 | 47 | 0 |
| 1985 | 62 | 0 |
| 1986 | 42 | 0 |
| 1987 | 38 | 0 |
| 1988 | 54 | 0 |
| 1989 | 55 | 0 |
| 1990 | 59 | 0 |
| 1991 | 62 | 0 |
| 1992 | 73 | 0 |
| 1993 | 85 | 0 |
| 1994 | 72 | 0 |
| 1995 | 70 | 0 |
| 1996 | 91 | 0 |
| 1997 | 129 | 0 |
| 1998 | 114 | 0 |
| 1999 | 117 | 0 |
| 2000 | 105 | 0 |
| 2001 | 108 | 30 |
| 2002 | 161 | 155 |
| 2003 | 137 | 215 |
| 2004 | 111 | 256 |
| 2005 | 114 | 231 |
| 2006 | 120 | 238 |
| 2007 | 111 | 205 |
| 2008 | 104 | 175 |
| 2009 | 164 | 208 |
| 2010 | 156 | 212 |
| 2011 | 120 | 191 |
| 2012 | 144 | 140 |
| 2013 | 148 | 133 |
| 2014 | 138 | 179 |
| 2015 | 141 | 186 |
| 2016 | 129 | 188 |
| 2017 | 184 | 181 |
| 2018 | 125 | 176 |
| 2019 | 151 | 161 |
| 2020 | 127 | 151 |
| 2021 | 121 | 132 |
| 2022 | 91 | 140 |
| 2023 | 87 | 169 |
| 2024 | 68 | 130 |
| 2025 | 89 | 132 |
| 2026 | 53 | 86 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Lactone and lactam containing compounds useful as immunomodulators1 Sep 2026US 12,723,041 B2Bristol-Myers Squibb Company
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Substituted triazine compound1 Oct 2026US 2026/0297040 A1
- Organic electroluminescent element and electronic device1 Oct 2026US 2026/0297107 A1Idemitsu Kosan Co., Ltd.
- Flame retardant, composition, and molded article1 Oct 2026US 2026/0297296 A1Adeka Corporation
Most cited
By later US patents
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Proline derivatives and related compounds230US 4,105,776 AE. R. Squibb & Sons, Inc. · 1978
- Azetidine-2-carboxylic acid derivatives180US 4,046,889 AE. R. Squibb & Sons, Inc. · 1977
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992